I期成人型卵巢颗粒细胞瘤的保守手术:MITO-9研究结果
MITO-9多中心研究纳入229例I期成人型卵巢颗粒细胞瘤患者,32.6%接受保留生育功能手术(FSS),67.4%接受根治性手术(RS)。中位随访84个月,FSS组10年无病生存率显著低于RS组(50% vs 74%,p=0.006),但总生存无差异;囊肿剔除术组无病生存显著差于单侧附件切除术组。
要点
- FSS组10年DFS显著低于RS组(50% vs 74%,p=0.006),但OS无差异。
- 囊肿剔除术组10年DFS显著差于USO组(16% vs 70%,p<0.001)。
- FIGO IC期和囊肿剔除术是多变量分析中较差生存的显著预测因素。
核心结论
- 本研究支持在I期成人型卵巢颗粒细胞瘤中,避免囊肿剔除术的前提下FSS具有肿瘤学安全性;USO应作为首选术式。
研究设计与样本
- MITO-9多中心研究,纳入229例明显I期成人型卵巢颗粒细胞瘤患者,32.6%接受FSS,67.4%接受RS。
主要发现
- 中位随访84个月,FSS组10年DFS为50%,RS组为74%,FSS组显著更差(p=0.006)。
- RS组与USO组10年DFS分别为75%和70%,无显著差异(p=0.5)。
- 囊肿剔除术组10年DFS为16%,USO组为70%,囊肿剔除术组显著更差(p<0.001)。
- 囊肿剔除术后继以USO组10年DFS为41%,USO组为70%,前者显著更差(p=0.05)。
- FSS与RS之间未检测到OS差异;多变量分析中FIGO IC期和囊肿剔除术保留对较差生存的显著预测价值。
临床怎么用
- 作者认为,在I期成人型卵巢颗粒细胞瘤中,避免囊肿剔除术的前提下FSS具有肿瘤学安全性,USO应作为首选术式。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: About 30% of Adult type granulosa cell tumors of the ovary (AGCTs) are diagnosed in fertile age. In stage I, conservative surgery (fertility-sparing surgery, FSS), either unilateral salpingo-oophorectomy (USO) or cystectomy are possible options. The aim of this study is to compare oncological outcomes of FSS and radical surgery (RS) in apparently stage I AGCTs treated within the MITO group (Multicenter Italian Trials in Ovarian cancer). METHODS: Survival curves were calculated using the Kaplan-Meier method and compared with log-rank test. The role of clinicopathological variables as prognostic factors for survival was assessed using Cox's regression. RESULTS: Two-hundred and twenty-nine patients were included; 32.6% received FSS, 67.4% RS. In the FSS group, 62.8% underwent USO, 16.7% cystectomy, 20.5% cystectomy followed by USO. After a median follow up of 84 months, median DFS was significantly worse in the FSS-group (10 yr DFS 50% vs 74%, in FSS and RS group, p = 0.006). No significant difference was detected between RS and USO (10 yr DFS 75% vs 70%, p = 0.5).Cystectomy-group showed a significantly worse DFS compared to USO (10 yr DFS 16% vs 70%, p < 0.001). Patients receiving cystectomy and subsequent USO showed a better prognosis, even though significantly worse compared to USO (10 yr DFS 41% vs 70%, p = 0.05). Between FSS and RS, no difference in OS was detected. At multivariate analysis, FIGO stage IC and cystectomy retained significant predictive value for worse survival. CONCLUSIONS: This study supports the oncological safety of FSS in stage I AGCTs, provided that cystectomy is avoided; USO should be the preferred approach.
引用
- Bergamini A, Cormio G, Ferrandina G, et al. Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study. Gynecol Oncol. 2019. PMID: 31189500. doi:10.1016/j.ygyno.2019.05.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。